Wilmington, NC, 4 August 2020 – Catalyst Clinical Research announced today that it has merged with Ce3, Inc. to expand its depth of oncology-specific therapeutic expertise. The combined company is strongly positioned to deliver oncology clinical development services...
Guilford, CT – June 26, 2018 Ce3 Inc., a Connecticut based CRO, has announced it is consolidating its data and biostatistics unit (Cd3, Inc.) into the Ce3 organization to form a single business unit effective July 1, 2018. Cd3 Inc. had been providing data management...
